Credit: K KStock/Adobe stock
A new lawsuit accuses the manufacturers, producers and distributors of popular weight-loss drugs Ozempic and Wegovy of knowingly advertising and selling the products despite their ability to cause severe gastrointestinal issues, without properly warning customers of the risks.
The product liability suit contends that the defendants have failed to warn users "about the true risks of their weight loss drugs, Wegovy and Ozempic," including plaintiff Billie Farley, who claims to have suffered serious injury as a result of the marketing of the drugs and her use of Ozempic.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
